Arizona is investing $14 million in its three state universities toward COVID-19 response efforts, including expanded wastewater monitoring and the Arizona State University Biodesign Institute’s development of a rapid, 20-minute saliva test. The Phoenix area hopes to double its contributions to a nationwide convalescent plasma donation effort to combat COVID-19. Meanwhile, Arizona health and school leaders continue to advocate for mask mandates and other precautions with hopes a second spike could be smaller.
ASU tapped to develop rapid, 20-minute COVID-19 saliva test / AZ Big Media
COVID infection rates up in 2 counties, no new business restrictions / Arizona Capitol Times
UA stay-at-home request coming to an end / Arizona Public Media
Scientists share findings of COVID-19 genomic research / Flagstaff Business News
UA incubator attracts stealthy, well-funded biotech startup Nanomoneo, Techletics / Arizona Daily Star
Techletics, a startup developing a mobile health app that helps people improve their posture, and Nanomoneo, a biotech instrument startup, have joined the University of Arizona Center for Innovation incubation program at the UA Tech Park.
Alzheimer’s risk, inhibiting cancer growth and pint-sized scientists / Inside Tucson Business
A finding from researchers at the University of Arizona indicates that women who have received hormone-modulating therapies for breast cancer are at a reduced risk for neurodegenerative diseases such as Alzheimer’s.
Banner Alzheimer’s Institute has received $10 million from the family of the late J. Orin Edson for innovative dementia care and caregiver support at one of its specialty memory centers.
Banner Health is implementing applied artificial intelligence technology—a computer-aided triage system that cuts down the time doctors use to look over imaging—to quickly treat patients suffering from a stroke.
Arizona Bioscience News will return on October 15.